Ocular Therapeutix Inc (OCUL) returns
Ocular Therapeutix returns over 10 years
$1,000 invested in Ocular Therapeutix ten years ago was worth $1,189 at the close on October 30, 2026, with dividends reinvested: an average return of 1.7% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -9.1% | — | $908.74 | -0.9% |
| 3 months | -17.7% | — | $822.90 | +2.1% |
| Year to date | -42.6% | — | $574.14 | +11.7% |
| 1 year | -41.0% | — | $589.68 | +12.4% |
| 3 years | +182.2% | +41.3% | $2,822 | +88.5% |
| 5 years | +5.0% | +1.0% | $1,050 | +76.0% |
| 10 years | +18.9% | +1.7% | $1,189 | +316.6% |
Ocular Therapeutix return by calendar year
| Year | OCUL | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -42.6% | +11.7% | -54.3% |
| 2025 | +42.2% | +17.7% | +24.4% |
| 2024 | +91.5% | +24.9% | +66.6% |
| 2023 | +58.7% | +26.2% | +32.5% |
| 2022 | -59.7% | -18.2% | -41.5% |
| 2021 | -66.3% | +28.7% | -95.1% |
| 2020 | +424.1% | +18.4% | +405.7% |
| 2019 | -0.8% | +31.2% | -32.0% |
| 2018 | -10.6% | -4.6% | -6.0% |
| 2017 | -46.8% | +21.7% | -68.5% |
| 2016 | -10.7% | +12.0% | -22.7% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: OCUL financials
No forecast, no recommendation. This page describes Ocular Therapeutix Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.